The relative contribution of viral and bacterial sexually transmitted infections on HIV acquisition in Southern African women in the methods for improving reproductive health in Africa study

International Journal of STD and AIDS

Volumn 22, Issue 4, 2011, Pages 218-224

  Venkatesh, K K ^a,b   van der Straten, A ^c,d   Cheng, H ^c   Montgomery, E T ^c   Lurie, M N ^a,b   Chipato, T ^e   Ramjee, G ^f   Blanchard, K ^g   Padian, N S ^b   Mayer, K H ^a,b   de Bruyn, G ^h  

^a Division of Infectious Diseases   (United States)

^b BROWN UNIVERSITY   (United States)

^c RTI INTERNATIONAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^f SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^g IBIS REPRODUCTIVE HEALTH   (United States)

^h UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

HIV AIDS Women HSV 2 HIV acquisition Africa Gonorrhoea

Indexed keywords

ADULT; AFRICA; ARTICLE; BACTERIAL INFECTION; BIOMEDICINE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GONORRHEA; GROUPS BY AGE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; NEISSERIA GONORRHOEAE; PHASE 3 CLINICAL TRIAL; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCTIVE HEALTH; RISK ASSESSMENT; RISK FACTOR; SEROCONVERSION; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VIRUS INFECTION;

ADULT; CASE-CONTROL STUDIES; CONDOMS; CONTRACEPTIVE DEVICES, FEMALE; FEMALE; GONORRHEA; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; LOGISTIC MODELS; NEISSERIA GONORRHOEAE; ODDS RATIO; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES; SOUTH AFRICA; TREATMENT OUTCOME; YOUNG ADULT; ZIMBABWE;

EID: 79955638427     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2010.010385     Document Type: Article

References (46)

1. UNAIDS. UNAIDS/WHO AIDS epidemic update. 2007. See http://www.unaids.org/epidemic-update/ (last checked 9 May 2008)
2. Human Sciences Research Council. South African National HIV Prevalence, Incidence, Behavior, and Communication Survey, 2008: A Turning Tide Among Teenagers? Cape Town, South Africa: HSRC Press, 2008
3. Bertozzi S, Laga M, Bautista-Arredondo S, Coutinho A. Making HIV prevention programmes work. Lancet 2008;372:831-844
4. Burns D, Dieffenbach CW, Vermund SH. Rethinking HIV-1 prevention. Clin Infect Dis 2010;51:725-731
5. Fox J, Fidler S. Sexual transmission of HIV-1. Antiviral Res 2010;85:276-285
6. Dosekun O, Fox J. An overview of the relative risks of different sexual behaviours on HIV transmission. Curr Opin HIV AIDS 2010;5:291-297
7. Todd J, Grosskurth H, Changalucha J, et al. Risk factors influencing HIV infection incidence in a rural African population: a nested case-control study. J Infect Dis 2006;193:458-466
8. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995;346:530-536
9. Wawer M, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 1999;353:525-535
10. Laga MMA, Kivuvu M, Malele B, et al. Non-ulcerative secually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993;7:95-102
11. Dallabetta G, Neilson G. Efforts to control sexually transmitted infections as a means to limit HIV transmission: what is the evidence? Curr Infect Dis Rep 2004;7:79-84
12. Halperin D, Epstein H. Concurrent sexual partnerships help to explain Africa's high HIV prevalence: implications for prevention. Lancet 2004;364:4-6
13. Røttingen J, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis 2001;28:579-597
14. Fleming D, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999;75:3-17
15. Grosskurth H, Gray R, Hayes R, Mabey D, Wawer M. Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet 2000;355:1981-1987
16. Corey L, Wald A, Celum CL, Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immun Defic Syndr 2004;35:435-445
17. Freeman E, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006;20:73-83
18. Glynn J, Biraro S, Weiss HA. Herpes simplex virus type 2: a key role in HIV incidence. AIDS 2009;23:1595-1598
19. Kaul R, Kimani J, Nagelkerke NJ, et al. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. J Am Med Assoc 2004;291:2555-2562
20. Zetola N, Bernstein KT, Wong E, Louie B, Klausner JD. Exploring the relationship between sexually transmitted diseases and HIV acquisition by using different study designs. J Acquir Immun Defic Syndr 2009;50:546-551
21. Padian N, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 2007;370:251-261
22. Van Der Pol B, Kwok C, Pierre-Louis B, et al.Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 2008;197:548-554
23. Quigley M, Morgan A, Malamba SS, et al. Case-control study of risk factors for incident HIV infection in rural Uganda. J Acquir Immun Defic Syndr 2000;23:418-425
24. Serwadda D, Gray RH, Sewankambo NK, et al. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda. J Infect Dis 2003;188:1492-1497
25. Orrorth K, Gavyole A, Todd J, et al. Syndromic treatment of sexually transmitted diseases reduces the proportion of incident HIV infections attributable to these diseases in rural Tanzania. AIDS 2000;14:1429-1437
26. Rothman K, Greenland S, Lash TL. Modern Epidemiology. 3rd edn. Philadelphia: Walters Kluwer, 2008
27. Greenland S, Thomas DC, Morgenstern H. The rare-disease assumption revisited. A critique of "estimators of relative risk for case-control studies". Am J Epidemiol 1986;124:869-883
28. Boera T, Weir SS. Integrating demographic and epidemiological approaches to research on HIV/AIDS: the proximate-determinants framework. J Infect Dis 2005;191(Suppl 1):S61-7
29. Lewis J, Donnelly CA, Mare P, Mupambireyi Z, Garnett GP, Gregson S. Evaluating the proximate determinants framework for HIV infection in rural Zimbabwe. Sex Transm Infect 2007;83(Suppl 1):i61-i69
30. Greenland S, Robins JM. Conceptual problems in the definition and interpretation of attributable fractions. Am J Epidemiol 1988;128:1185-1197
31. Greenland S, Drescher K. Maximum likelihood estimation of the attributable fraction from logistic models. Biometrics 1993;49:865-872
32. Szklo M, Nieto FJ. Epidemiology Beyond the Basics. 2nd edn. Sudbury, MA: Jones and Bartlett Publishers, 2006
33. del Mar Pujades Rodríguez M, Obasi A, Mosha F, et al. Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS 2002;16:451-462
34. Baeten J, Benki S, Chohan V, et al. Hormonal contraception use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS 2007;21:1771-1777
35. Brown J, Wald A, Hubbard A, et al. Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe. AIDS 2007;21:1515-1523
36. Zhu J, Hladik F, Woodward A, et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med 2009;15:886-892
37. Moriuchi M, Moriuchi H, Williams R, Straus SE. Herpes simplex virus infection induces replication of human immunodeficiency virus type 1. Virology 2000;278:534-540
38. Benedetti J, Zeh J, Corey L. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med 1999;131:14-20
39. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008;358:1560-1571
40. Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008;371:2109-2119
41. Korenromp E, White RG, Orroth KK, et al. Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials. J Infect Dis 2005;191:S168-S178
42. Gray R, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001;357:1149-1153
43. Cohen M, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997;349:1868-1873
44. Sexton J, Garnett G, Røttingen JA. Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection. Sex Transm Dis 2005;32:351-357
45. Napierala Mavedzenge S, Van Der Pol B, Cheng H, et al. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex Transm Dis 2010;37:460-466
46. Rosenblum M, Jewell NP, van der Laan M, Shiboski S, van der Straten A, Padian A. Analyzing direct effects in randomized trials with secondary interventions: an application to human immunodeficiency virus prevention trials. J Roy Stat Soc 2009;172(Part 2):443-465